[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fW8h6UtSFnWwcK7PkwUEnxwJQYPbA2zvfHQMqKjYwV_w":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":7,"truncated":8,"activeTrials":9,"phase3Count":10,"totalEnrollment":11,"activePrograms":12,"nonDrugCount":13,"topConditions":14,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"Ohio University",[4,6],"Ohio University College of Osteopathic Medicine",66,false,8,2,16596,0,64,[15,18,20,23,25,27,30,32],{"name":16,"count":17},"Cardiovascular Diseases",6,{"name":19,"count":17},"Overweight and Obesity",{"name":21,"count":22},"Hypertension",5,{"name":24,"count":22},"Dyslipidemias",{"name":26,"count":22},"Low Back Pain",{"name":28,"count":29},"Blood Donors",4,{"name":31,"count":29},"Diabetes Mellitus",{"name":33,"count":29},"Aging",[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[43,71,89,115],{"intervention":44,"totalTrials":45,"cells":46},"Intensive insulin",1,{"EARLY_PHASE1":47,"PHASE1":49,"PHASE2":51,"PHASE3":53,"PHASE4":55,"NA":69},{"trials":48,"activeCount":12},[],{"trials":50,"activeCount":12},[],{"trials":52,"activeCount":12},[],{"trials":54,"activeCount":12},[],{"trials":56,"activeCount":12},[57],{"nctId":58,"briefTitle":59,"status":60,"phases":61,"primaryCompletion":62,"completion":62,"start":63,"enrollment":64,"conditions":65,"interventions":67},"NCT01087567","INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes","COMPLETED",[40],"2014-01","2010-07",23,[66],"Type 2 Diabetes",[44,68],"Routine Care",{"trials":70,"activeCount":12},[],{"intervention":68,"totalTrials":45,"cells":72},{"EARLY_PHASE1":73,"PHASE1":75,"PHASE2":77,"PHASE3":79,"PHASE4":81,"NA":87},{"trials":74,"activeCount":12},[],{"trials":76,"activeCount":12},[],{"trials":78,"activeCount":12},[],{"trials":80,"activeCount":12},[],{"trials":82,"activeCount":12},[83],{"nctId":58,"briefTitle":59,"status":60,"phases":84,"primaryCompletion":62,"completion":62,"start":63,"enrollment":64,"conditions":85,"interventions":86},[40],[66],[44,68],{"trials":88,"activeCount":12},[],{"intervention":90,"totalTrials":45,"cells":91},"Propranolol or nadolol",{"EARLY_PHASE1":92,"PHASE1":94,"PHASE2":96,"PHASE3":98,"PHASE4":100,"NA":113},{"trials":93,"activeCount":12},[],{"trials":95,"activeCount":12},[],{"trials":97,"activeCount":12},[],{"trials":99,"activeCount":12},[],{"trials":101,"activeCount":12},[102],{"nctId":103,"briefTitle":104,"status":60,"phases":105,"primaryCompletion":106,"completion":106,"start":107,"enrollment":108,"conditions":109,"interventions":111},"NCT00910689","Drug and Non-Drug Treatment Of Severe Migraine",[40],"2005-11","2001-07",232,[110],"Migraine Headache",[90,112],"Optimal Acute Therapy",{"trials":114,"activeCount":12},[],{"intervention":112,"totalTrials":45,"cells":116},{"EARLY_PHASE1":117,"PHASE1":119,"PHASE2":121,"PHASE3":123,"PHASE4":125,"NA":131},{"trials":118,"activeCount":12},[],{"trials":120,"activeCount":12},[],{"trials":122,"activeCount":12},[],{"trials":124,"activeCount":12},[],{"trials":126,"activeCount":12},[127],{"nctId":103,"briefTitle":104,"status":60,"phases":128,"primaryCompletion":106,"completion":106,"start":107,"enrollment":108,"conditions":129,"interventions":130},[40],[110],[90,112],{"trials":132,"activeCount":12},[]]